Selectins and their ligands mediate leukocyte rolling, allowing interactions with chemokines that lead to integrin activation and arrest. Here we show that E-selectin is crucial for generating a secondary wave of activating signals, transduced specifically by E-selectin ligand-1, that induces polarized, activated a M b 2 integrin clusters at the leading edge of crawling neutrophils, allowing capture of circulating erythrocytes or platelets. In a humanized mouse model of sickle cell disease, the capture of erythrocytes by a M b 2 microdomains leads to acute lethal vascular occlusions. In a model of transfusion-related acute lung injury, polarized neutrophils capture circulating platelets, resulting in the generation of oxidative species that produce vascular damage and lung injury. Inactivation of E-selectin or a M b 2 prevents tissue injury in both inflammatory models, suggesting broad implications of this paradigm in thromboinflammatory diseases. These results indicate that endothelial selectins can influence neutrophil behavior beyond its canonical rolling step through delayed, organ-damaging, polarized activation.
Selectins and their ligands mediate leukocyte rolling, allowing interactions with chemokines that lead to integrin activation and arrest. Here we show that E-selectin is crucial for generating a secondary wave of activating signals, transduced specifically by E-selectin ligand-1, that induces polarized, activated a M b 2 integrin clusters at the leading edge of crawling neutrophils, allowing capture of circulating erythrocytes or platelets. In a humanized mouse model of sickle cell disease, the capture of erythrocytes by a M b 2 microdomains leads to acute lethal vascular occlusions. In a model of transfusion-related acute lung injury, polarized neutrophils capture circulating platelets, resulting in the generation of oxidative species that produce vascular damage and lung injury. Inactivation of E-selectin or a M b 2 prevents tissue injury in both inflammatory models, suggesting broad implications of this paradigm in thromboinflammatory diseases. These results indicate that endothelial selectins can influence neutrophil behavior beyond its canonical rolling step through delayed, organ-damaging, polarized activation.
Leukocytes are recruited to inflamed areas by a tightly regulated cascade of adhesive and signaling events that choreograph their migration. Neutrophil (PMN) rolling is mediated by endothelial P-and E-selectins (encoded by the Selp and Sele genes, respectively) [1] [2] [3] . Three glycoproteins-P-selectin glycoprotein ligand-1 (PSGL-1, encoded by Selplg), E-selectin ligand-1 (ESL-1, encoded by Glg1), and CD44 (encoded by Cd44)-mediate the physiological binding of mouse PMNs to endothelial selectins through highly specialized contributions 4 . Leukocyte rolling is followed by a first wave of endothelial signals that activate integrins, allowing firm arrest. Although G-protein coupled receptor-induced signaling triggered by chemokines is the best-characterized activating pathway, recent studies have uncovered physiological signaling functions for E-selectin ligands. On rolling leukocytes, CD44-mediated signaling participates in receptor redistribution 4 , whereas PSGL-1 induces partial activation of a L b 2 integrin 5 . Although the Glg1 sequence is similar to that of the gene encoding chicken cysteine-rich fibroblast growth factor receptor 6 , it remains unknown whether ESL-1 can transduce signals. E-selectin engagement can activate the integrin a M b 2 (also known as CD11b/ CD18 or Mac-1) on PMNs 7, 8 , but the specific E-selectin ligand involved in this process has not been identified. a M b 2 promiscuously binds endothelial counter-receptors, matrix and plasma proteins 9 , the complement fragment C3b 10 and the platelet receptor GPIba (ref. 11) , thus contributing to leukocyte recruitment and platelet adhesion.
During recruitment, leukocytes rapidly polarize, redistributing chemokine receptors 12 , activated b 2 integrins 13 and actin-remodeling GTPase clusters 14 at their leading edge, whereas the trailing edge (uropod) is enriched in heavily glycosylated proteins (for example, PSGL-1, L-selectin and CD43) and other components involved in membrane retraction 12, 14 . These microdomains are important for the directional, chemokine-driven movement of leukocytes within blood vessels and across the endothelium.
Activated neutrophils recruited to inflamed areas mediate both acute and chronic organ injury-infusion or increased numbers of neutrophils in circulation is sufficient to promote organ damage, whereas depletion of neutrophils can curb organ damage in multiple experimental or clinical settings [15] [16] [17] . In sickle cell disease (SCD), alterations in the sickle red blood cell (sRBC) structure cause a proinflammatory phenotype that promotes acute vaso-occlusive episodes 18, 19 . In a humanized mouse model of SCD, PMNs capture circulating sRBCs, and the rate of these interactions correlates with the decrease in microcirculatory blood flow and with death 20, 21 . The molecular basis of these interactions, however, has not yet been elucidated. Individuals with SCD and other acutely ill individuals requiring blood transfusions are at risk of transfusion-related acute lung injury (TRALI), the most prevalent cause of transfusion-associated morbidity, in which antibodies against the recipient's PMNs or other bioactive mediators from the transfused blood can elicit organ injury 22, 23 .
Here we demonstrate that the generation of activated integrin microdomains at the leading edge of PMNs emerges from secondary signaling events induced by endothelial E-selectin and drives vascular damage in TRALI and SCD through heterotypic interactions.
RESULTS

Heterotypic interactions are induced during inflammation
We examined the cremasteric vasculature of wild-type mice after surgical trauma or after the administration of tumor necrosis factora (TNF-a). Brightfield intravital microscopy revealed frequent interactions between adherent leukocytes and RBCs carrying normal hemoglobin (nRBCs) in cytokine-activated venules (Fig. 1a,b) . These interactions tend to occur in venules with relatively low shear rates (o500 s -1 ) and can last up to several seconds (Supplementary Video 1 online). Endogenous platelets, identified by in vivo labeling with a CD41-specific antibody 24 ( Fig. 1a and Supplementary Video 2 online), also interacted with adherent leukocytes in venules after surgical manipulation, and these interactions were strongly enhanced after TNF-a treatment (Fig. 1c) . We mapped the leukocyte microdomains mediating these interactions by high-speed multichannel fluorescence intravital microscopy (MFIM) using clustered L-selectin expression as a marker of the trailing edge 25 . The interactions of nRBCs with leukocytes adherent in inflamed venules were mediated almost exclusively by the leukocytes' leading edge ( Fig. 1d and Supplementary Video 1). The interactions of platelets with leukocytes adherent in noninflamed venules (surgical trauma alone) were mediated by both the leukocytes' trailing and leading edges (Fig. 1e) . However, after cytokine-induced inflammation, the marked increase in platelet interactions was mediated by the leading edge (Fig. 1e) . These results indicate differential contributions of leukocyte microdomains in mediating interactions with blood components under inflammatory conditions.
Interactions are regulated by E-selectin and mediated by a M b 2 In a humanized mouse model of SCD, we have previously shown that endothelial selectins participate in leukocyte recruitment and vasoocclusion 21 . We thus investigated the individual roles of each endothelial selectin in the capture of nRBCs. The rate of nRBC interactions per adherent leukocyte was significantly reduced in E-selectin-deficient (Sele -/-) but not P-selectin-deficient (Selp -/-) mice compared to Figure 1 Heterotypic interactions of RBCs and platelets with leukocyte microdomains are induced during inflammation. (a) Heterotypic interactions between leukocytes and platelets in the cremasteric circulation of a TNF-a-stimulated C57BL/6 mouse. Fluorescently conjugated antibodies to L-selectin (blue) and CD41 (red) allowed identification of the trailing edge of crawling leukocytes and platelets, respectively. Brightfield (top left) and fluorescence channels were used for acquisition and merged (bottom right). The short arrow indicates an interacting RBC, and the asterisks show interacting platelets (green for those mediated by the trailing edge and white for the leading edge). The large arrow points in the direction of blood flow. Scale bar, 10 mm. S B 2 0 3 5 8 0 P ic e a t a n n o l wild-type mice (Fig. 2a) . A similar reduction in platelet capture by adherent leukocytes was found in Sele -/-mice ( Fig. 2b) , with capture at the leading edge primarily affected (Fig. 2c) . As E-selectin expression is restricted to the endothelium, these results suggest that signals emanating from the endothelial cells, transmitted by E-selectin ligands into leukocytes, regulate heterotypic interactions with nRBCs and platelets. Because PSGL-1, ESL-1 and CD44 account for virtually all selectin binding activity on mouse PMNs 4 , we evaluated the behavior of circulating RBCs in Selplg -/-mice, Cd44 -/-mice and lethally irradiated mice reconstituted with hematopoietic cells transduced with a lentiviral vector carrying a short hairpin RNA interference construct targeting Glg1 (shESL-1) that eliminates surface ESL-1 expression (see Methods and ref. 4 ). Although we did not observe a significant reduction in nRBC capture in mice lacking either PSGL-1 or CD44 (Fig. 2d) , we found a marked reduction in nRBC interactions with shESL-1-transduced leukocytes compared to their interactions with either untransduced leukocytes in the same venules or with leukocytes transduced with a scrambled short hairpin control in control chimeric mice (Fig. 2e) . These results suggest that ESL-1 is the E-selectin ligand that mediates the activating signals allowing heterotypic interactions during inflammation. Furthermore, inhibition of Src family kinases, but not of p38 mitogen-activated protein kinase (MAPK) or spleen tyrosine kinase (Syk), led to a decrease in the frequency of nRBCleukocyte interactions (Fig. 2f ) comparable to that found in Sele -/-mice or shESL-1-transduced mice, suggesting a role for Src family kinases in transducing these activating signals.
Activated b 2 integrins have been reported to localize at the leading edge of adherent leukocytes 13 , and their activity can be modulated by E-selectin and Src family kinases 5, 7, 8, 26, 27 . We thus hypothesized that a M b 2 integrin might be the receptor mediating heterotypic interactions. High-speed MFIM analyses revealed that a M b 2 integrin was homogeneously expressed on the surface of adherent leukocytes, including areas interacting with nRBCs ( Fig. 3a) . We observed a marked reduction in the number of nRBCs interacting with leukocytes deficient in a M integrin (encoded by Itgam; Fig. 3b ) despite similar RBC counts among all groups (Supplementary Table 1 online). In agreement with this finding, Selplg -/-leukocytes, which had an increased frequency of interactions with nRBCs ( Fig. 2d) , expressed higher amounts of a M b 2 integrin compared to wild-type leukocytes (Supplementary Fig. 1 online) . Notably, leukocytes from mice deficient in the C3 complement protein, a ligand for a M b 2 integrin 10 , showed a significant, but partial, decrease in the frequency of nRBC interactions ( Supplementary Fig. 2 online), suggesting that complement opsonization of nRBCs is involved in RBC capture. Itgam -/-leukocytes also had a substantial reduction in the frequency of platelet interactions compared to wild-type leukocytes (Fig. 3c) . This decrease was not as marked as that for nRBCs, probably owing to integrin-independent interactions between platelets and leukocytes at the trailing edge (Fig. 3d) . These data indicate that integrin a M b 2 is the receptor mediating heterotypic interactions at the leading edge of adherent leukocytes and that its activity is increased during inflammation. investigate this hypothesis, we developed a new in vivo assay to determine a M b 2 integrin activity on adherent leukocytes in real time. We took advantage of the ability of denatured albumin to bind leukocytes in a b 2 integrin-dependent manner 28 . We coated fluorescent beads (fluospheres; 1 mm in diameter) with albumin and tracked their behavior by high-speed MFIM after intravenous injection into mice treated with TNF-a (Supplementary Video 3 online). Albumin-coated fluospheres bound exclusively Gr-1 + leukocytes, of which the vast majority were PMNs (Gr-1 + and negative for the monocyte and macrophage marker F4/80; Fig. 4a ). Binding was specific, as fluospheres coated with polyvinyl alcohol were not captured by leukocytes ( Supplementary Fig. 3 online) . Fluosphere binding was mediated by the leading edge of adherent PMNs ( Fig. 4b and Supplementary Video 3) and was virtually absent in Itgam -/-mice (Fig. 4c) . In addition, a M b 2 protein expression in vivo strongly correlated with avidity (fluosphere capture) ( Supplementary  Fig. 4 online). We next used the fluosphere binding assay to determine whether Eselectin engagement could modulate a M b 2 integrin activity in vivo.
ESL-1 regulates
Fluosphere binding in Sele -/-venules was significantly reduced compared to wild-type controls or Selp -/-venules (Fig. 4d) . Furthermore, although fluosphere binding was not lessened in mice lacking PSGL-1 or CD44 compared to wild-type controls (Fig. 4e) , a marked reduction was found in leukocytes transduced with the shESL-1 vector (Fig. 4f) . These results indicate that ESL-1 regulates regional avidity on the surface of adherent PMNs in vivo.
Platelet-neutrophil interactions induce organ injury in TRALI
We next asked whether the induction of heterotypic interactions through E-selectin-mediated modulation of a M b 2 activity might underlie the vascular injury that characterizes acute inflammatory processes. Intravenous injection of an antibody specific for major histocompatibility complex type I (haplotype H2d) into BALB/c mice has been used to model TRALI, a process that requires the presence of PMNs 17 . We induced lung injury in BALB/c mice, as assessed by protein accumulation in the alveolar spaces, by intravenous injection of H2d-specific antibody (Fig. 5a) . A moderate thrombocytopenia developed in these mice (Fig. 5b) , suggesting that platelets might be involved in pulmonary pathogenesis in this model. Platelet depletion before administration of the H2d-specific antibody indeed resulted in complete abrogation of protein leakage into the bronchoalveolar space (Fig. 5a,b) without affecting PMN recruitment to the lungs (data not shown). To investigate the intravascular events leading to the vascular injury that results from H2d-specific antibody administration, we used high-speed MFIM to observe heterotypic interactions in the cremasteric circulation in mice pretreated with TNF-a before and after antibody administration. We used the cremaster muscle because it is more amenable than the lungs to detailed analyses of intravascular events in live mice. Antibody treatment significantly increased the number of platelet interactions with the leading edge of adherent leukocytes ( Fig. 5c,d ; Supplementary Video 4 online), which were inhibited by blocking E-selectin (Fig. 5c) . Furthermore, antibody to H2d markedly increased the permeability of cremasteric venules, as determined by quantification of fluorescence intensities of extravascular FITC-dextran (Fig. 5e,f) , and this increased permeability was prevented in platelet-depleted mice (Fig. 5g) . To determine the role of E-selectin-induced a M b 2 integrin activation, we treated other groups of mice with antibodies against E-selectin (clone 9A9) or a M b 2 (clone M1/70) before the H2d-specific antibody challenge. Vascular permeability was markedly reduced after treatment with either E-selectin or a M b 2 antibodies (Fig. 5f) . Furthermore, blocking E-selectin or a M b 2 , but not P-selectin, strongly decreased lung injury ( Fig. 5h) . We found a similar protective effect when we injected inhibitors of Src family kinases, but not when we injected inhibitors of Syk or p38 MAPK, into mice before treatment with H2d-specific antibody ( Supplementary Fig. 5 online) . To investigate the potential role of tissue-damaging reactive oxygen species (ROS), we used a fluorescent probe to evaluate ROS formation on adherent neutrophils by MFIM. Infusion with H2d-specific antibody rapidly increased the frequency of ROS-producing adherent leukocytes ( Fig. 5i and Supplementary Fig. 6 online) . Platelet depletion or E-selectin inhibition before antibody treatment markedly decreased the number of ROS-producing leukocytes (Fig. 5i) . In agreement with these observations, pretreatment with N-acetyl-cysteine, a ROS-scavenging molecule, completely prevented the increase in vascular permeability ( Supplementary Fig. 7 online) and the lung injury induced by treatment with H2d-specific antibody (Fig. 5j) . Taken together, these data indicate that E-selectin-induced a M b 2 integrin activation result in platelet capture at the leading edge of neutrophils and that a M b 2 engagement, in turn, triggers the generation of ROS that produce vascular and organ injury.
Interactions with sRBCs trigger vaso-occlusion in SCD
Interactions between sRBCs and adherent leukocytes can trigger vasoocclusion and death in a humanized mouse model of SCD 21 . In SCD mice (described in detail in the Methods section), surgical trauma alone induces a robust recruitment of leukocytes in cremasteric venules in the first 90 min after surgery ( Supplementary Fig. 8  online) . Video recordings of the same venules after systemic administration of TNF-a 91-180 min and 181-270 min after surgery revealed a further increase in leukocyte recruitment ( Supplementary  Fig. 8) . A fraction of circulating sRBCs was captured by adherent leukocytes, and the rate of interactions per leukocyte increased with the administration of TNF-a ( Fig. 6a and Supplementary Fig. 8) , eventually leading to a reduction in blood flow and often leading to death of the mouse 21 . Notably, the rate of RBC-leukocyte interactions was significantly elevated in SCD mice compared to control mice (1.88 ± 0.66 interactions per leukocyte per min versus 0.26 ± 0.04 interactions per leukocyte per min at 490 min after TNF-a injection, P o 0.001). Using high-speed MFIM, we previously identified PMNs as the leukocyte subset mediating the vast majority of sRBC captures in SCD 25 . The induction of sRBC-leukocyte interactions after cytokine administration was not due to the recruitment of more neutrophils at later times, because the proportion of adherent CD45 + Gr-1 + F4/80 -PMNs, relative to adherent lymphocytes and monocytes, did not significantly change during the three viewing periods at 0-90 min, 91-180 min and 181-270 min after surgery ( Supplementary Fig. 9 online) .
To determine whether E-selectin was involved in the increased frequency of heterotypic interactions observed in SCD mice after TNF-a administration, we generated SCD mice lacking endothelial Eselectin or P-selectin by transplanting bone marrow from SCD mice into lethally irradiated Sele -/-or Selp -/-mice, or we blocked these adhesion molecules in SCD mice using monoclonal antibodies. Although the numbers of adherent leukocytes recruited in the three viewing periods in these mice were similar to those in control SCD mice ( Supplementary Fig. 10 online) , the number of sRBC interactions per leukocyte was markedly decreased in the absence of functional E-selectin (Fig. 6a) , resulting in significant improvement in blood flow in the microcirculation (Fig. 6b) . Moreover, the absence of functional E-selectin improved the survival of SCD mice during the experimental period (Supplementary Table 1 ). In contrast, absence or inhibition of P-selectin had a partial effect, with the number of interactions, flow rate and survival similar to those in SCD control mice at later time points (Fig. 6a,b and Supplementary Table 1) .
Elevated a M b 2 activity mediates vaso-occlusion The increased rate of sRBC captures in SCD mice compared to those of nRBCs in wild-type mice might be explained by upregulation of a M b 2 integrin activity on adherent PMNs in SCD mice. Accordingly, in vivo analysis of a M b 2 integrin activity on SCD adherent leukocytes revealed a marked increase in the number of captured fluospheres compared to that in control hemizygous mice (a threefold increase, P o 0.0001; Fig. 6c,d) . This was largely due to the presence of a subset of leukocytes with marked integrin activation, as 18% of adherent leukocytes in SCD mice captured Z8 beads, compared to 1.5% of adherent leukocytes in control hemizygous mice ( Supplementary  Fig. 11 online) . Moreover, in the absence of E-selectin, a M b 2 integrin activity on adherent leukocytes was reduced in SCD mice to levels similar to those found in control hemizygous mice (Fig. 6d) . These results further emphasize the crucial role of E-selectin in regulating regional a M b 2 activity on adherent PMNs. To test whether a M b 2 integrin mediates sRBC-leukocyte interactions, we injected SCD mice with a M b 2 integrin-specific antibody or isotype control antibody 70 min after injection of TNF-a (Fig. 6e) . Administration of a M b 2 integrin-specific antibody decreased the rate of interactions between sRBCs and leukocytes by 79%, compared with control antibody (Fig. 6f) . Furthermore, a M b 2 -specific antibody treatment significantly increased wall shear rate (740 ± 62 s -1 in isotype control mice versus 933 ± 58 s -1 in M1/70-treated mice; P o 0.05) and significantly prolonged survival after TNF-a treatment (Fig. 6g) . These data indicate that E-selectin expressed during the inflammatory response in SCD mice triggers regional activation of leukocyte a M b 2 integrin that promotes sRBC interactions with intravascular leukocytes and vaso-occlusion.
DISCUSSION
Intravascular accumulation and activation of PMNs to localized inflamed areas can result in vascular and organ damage. Beyond the endothelium's role in promoting the recruitment of inflammatory leukocytes, we show here that the endothelium sends additional activating signals that are crucial for vascular injury. These E-selectin-mediated signals are transduced via ESL-1 and locally activate the integrin a M b 2 at the leading edge of crawling neutrophils. Activated a M b 2 clusters mediate heterotypic interactions with circulating RBCs and platelets, which can produce vascular occlusion and damage. The protection from organ injury or death observed after targeting of this pathway in two distinct disease models suggests that this paradigm may have broad implications in other thromboinflammatory diseases.
A primary source of leukocyte activating signals are G-protein coupled receptors, which upregulate integrin binding activity and promote arrest of rolling leukocytes 29, 30 . Much less is known, however, about the events taking place after leukocytes have adhered. MFIM analyses have revealed that most adherent myeloid leukocytes (Gr-1 + ) are actively migrating, presumably searching for a site of extravasation 25 , and show a polarized appearance in vivo, with clustered L-selectin at the uropod 25 . We used this marker to map the heterotypic interactions at the leading edge of crawling PMNs during inflammatory conditions, and we show that although a M b 2 integrin is expressed homogenously on the cell surface, its activity is specifically enhanced at the leading edge. Leukocyte polarity is crucial for their migration, as cells must reorganize chemokine receptors, integrins and various signaling and cytoskeletal constituents for directional migration 14 . Clustered activation of a leukocyte integrin is thus directly involved in disease pathogenesis through the generation of intravascular heterotypic interactions.
In vitro studies have shown that endothelial selectins can transduce signals into leukocytes 7, 28, 31, 32 . In vivo, PSGL-1 signaling through Syk can activate a L b 2 integrin, favoring slow rolling on intercellular adhesion molecule-1 (ref. 5), whereas CD44 can induce receptor clustering on slow rolling leukocytes through p38 MAPK signaling 4 . The present studies indicate that a third selectin ligand, ESL-1, is a functional signaling receptor on leukocytes but that it acts unexpectedly much later during the inflammatory cascade, beyond the classical rolling step. ESL-1-mediated signals are transduced at least in part by Src family kinases and affect the behavior of leukocytes that have adhered firmly to the endothelium, resulting in regional activation of a M b 2 integrin. Although the Src family kinase inhibitor (PP2) used in these experiments could potentially affect the activity of other kinases, the inhibitor is more potent (that is, it has a lower half-maximal inhibitory concentration) for Src family kinase members compared to other kinases; in addition, studies in animals with genetic deficiencies in Src family kinases have shown effects on a M b 2 integrin activity 16 , further supporting a role for these kinases in ESL-1-mediated signaling affecting a M b 2 integrin. These observations highlight the diversity of E-selectin ligand signaling in neutrophils, which trigger distinct activating phenomena. Although P-selectin can also activate a M b 2 integrin through Src family kinases at early stages of leukocyte recruitment to promote adhesion 33 , we show that this selectin is not required for the induction of heterotypic interactions in arrested leukocytes. Thus, the timing of a M b 2 activation may dictate the neutrophil response in inflamed venules.
Our study also underscores the bidirectional signaling capacity of a M b 2 integrin. ESL-1 can trigger 'inside-out' a M b 2 activation at the leading edge of PMNs; in turn, the engagement of platelets by activated a M b 2 can trigger 'outside-in' signals in PMNs leading to ROS generation 34, 35 that produces vascular damage in a model of TRALI. Engagement of a M b 2 integrin has been shown to induce granular release and elicit vascular damage in a model of hemorrhagic vasculitis 16 . Interactions of platelets with neutrophils through Pselectin and PSGL-1 may also contribute to lung injury after acid challenge 36 , raising the possibility that different stimuli may promote inflammation through distinct leukocyte microdomains. Because infusion of the H2d-specific antibody causes vascular injury outside the lung 17 , and given the inherent difficulties of imaging microdomains and rapid cell-to-cell interactions in the pulmonary circulation of live mice, we have used high-speed MFIM in the cremasteric microcirculation to obtain mechanistic insight. Our results indicate that E-selectin is necessary to initiate a second wave of activation that upregulates a M b 2 integrin at the leading edge of neutrophils, allowing platelet capture, which induces the formation of ROS by neutrophils and leads to vascular damage.
Key mechanistic differences in leukocyte recruitment have been noted for the lung compared to other tissues 37 . For example, neutrophils do not require selectin-mediated rolling to sequester in the lung. However, the E-selectin-mediated secondary wave of activation described here occurs when neutrophils are crawling in inflamed venules, after the canonical rolling step. Several studies have documented induction of E-selectin expression in the lung microvasculature after inflammatory stimuli 38 . Although we cannot be certain that the MFIM observations in cremasteric venules reported here reflect events in the pulmonary microcirculation, we have shown that all of the key components affecting permeability in the cremasteric vasculature during TRALI (E-selectin, a M b 2 integrin, platelets and ROS) are also crucial for lung injury, suggesting that the same fundamental mechanisms are at work in both tissues.
We identified complement C3 as one of the physiological a M b 2 ligands involved in RBC interactions, possibly by forming a bridge between the integrin and a yet uncharacterized receptor on aged or damaged RBCs 39 . Elevated levels of C3 bound to in vitro deoxygenated sRBCs and to sRBCs from hospitalized individuals with SCD have been observed 40 , suggesting that C3 may indeed have a major role in the pathogenesis of vaso-occlusion. Another candidate ligand for a M b 2 integrin expressed on sRBCs that could be involved in these interactions is the Landsteiner-Wiener glycoprotein (also known as intercellular adhesion molecule-4; ref. 41) , whose contribution to vaso-occlusion alone or in conjunction with C3 deserves future study. The physiological function of the inducible interactions between normal RBCs and adherent PMNs during inflammation remains undetermined. These interactions may serve a hemostatic role by removing damaged or old RBCs or by modulating platelet function through the release of ADP 42 or other ADP-independent 43 pathways by neighboring RBCs. Numerous clinical studies have linked leukocytosis with ischemic heart disease 44 . Alterations of vascular permeability induced by leukocyte recruitment might be associated with a greater need for platelet adhesion to maintain vascular integrity during an inflammatory challenge. Notably, RBC interactions were most prevalent at relatively low shear rates, consistent with in vitro studies using microcapillary flow chambers 45 . PMN activation may cause vessel wall injury that could eventually lead to deep vein thrombosis 46 .
In view of the finding that granulocyte colony-stimulating factor administration can enhance E-selectin ligand expression on human leukocytes 47 , our data provide a mechanistic explanation for the severe complications observed in granulocyte colony-stimulating factortreated individuals with SCD, including the induction of sickle cell crises and acute lung injury 15, 48 , and the predisposition for TRALI in patients treated with this cytokine 23 . Furthermore, these observations offer new candidate targets for the rational design of therapies for SCD, TRALI and possibly other types of inflammatory or ischemic vascular disease.
METHODS
Mice. We purchased C57BL/6 and BALB/c mice from the US National Cancer Institute. Berkeley sickle cell mice (Tg(Hu-miniLCRa1 G g A gdb S ) Hba-deficient Hbb-deficient), referred to as SCD mice, and control hemizygous mice (Tg(Hu-miniLCRa1 G g A gdb S ) Hba-deficient Hbb-heterozygous) mice have been previously described 21, 49 . Both groups of SCD mice have a mixed genetic background (H2b haplotype with contributions from C57BL/6, 129Sv, FVB/N, DBA/2 and Black Swiss) 21 . We purchased Cd44 -/-, Itgam -/-and C3 -/-mice from the Jackson Laboratory. We backcrossed the Selplg -/-(B6.Cg-Selplg tm1Fur /J, Jackson Laboratory), Selp -/-and Sele -/-mice 2 into the C57BL/6 background for at least seven generations. We determined the genotypes of all mice by PCR. We housed all mice at the Mount Sinai School of Medicine barrier facility. Experimental procedures performed on the mice were approved by the Animal Care and Use Committee of Mount Sinai School of Medicine.
Bone marrow transplantation. We generated SCD mice with or without additional genetic deficiencies by transplantation of bone marrow nucleated cells into lethally irradiated recipients as previously described 20 .
Brightfield intravital microscopy. We performed brightfield intravital microscopy using video recordings as previously reported 20, 21 . For SCD mice, we recorded several postcapillary and collecting venules from 15 min after the surgical preparation (time 0 is surgical sectioning of the cremaster muscle) for 75 min (before administration of TNF-a), with each venule recorded continuously for at least 2 min. We then intraperitoneally injected SCD mice with 0.5 mg recombinant mouse TNF-a (R & D Systems) and videotaped the same venules over a period of 90 min (91-180 min), after which we recorded the venules again for another 90 min (181-270 min). We evaluated the role of endothelial selectins in identical experiments performed in Selp À/À or Sele À/À mice transplanted with bone marrow cells from SCD donor mice or in experiments using antibodies against P-or E-selectin (1 mg per kg body weight) before surgery. In some experiments, we infused 1 mg per kg body weight of antibody to a M integrin (clone M1/70) subunit or IgG isotype control (IgG2b,k) through a carotid artery catheter into mice 70 min after treatment with TNF-a. In experiments with non-SCD C57BL/6 mice, we administered TNF-a intrascrotally and recorded images 160-210 min after cytokine injection. In some experiments, we injected mice with the Src family kinase inhibitor PP2 (150 mg per kg body weight), the p38 inhibitor SB203580 (100 mg per mouse; both from Calbiochem), the Syk inhibitor piceatannol (1 mg per mouse; Alexis Biochemicals) or an equivalent volume of vehicle (DMSO) 120 min after TNF-a administration.
Hemodynamic measurements and image analyses for brightfield intravital microscopy. We measured the venular diameter with a video caliper. We measured centerline RBC velocity for each venule in real time with an optical Doppler velocimeter (Texas A&M). We calculated the wall shear rate (g) on the basis of Poiseuille's law for a newtonian fluid: g ¼ 2.12(8V mean ) / D v , where D v is the venule diameter, V mean is the mean velocity estimated as V RBC / 1.6, and 2.12 is a median empirical correction factor obtained from actual velocity profiles measured in microvessels in vivo. We calculated blood flow rate from the formula V mean pd 2 / 4. We performed all analyses by playback assessment of videotapes as previously described 20, 21 .
High-speed multichannel fluorescence intravital microscopy. We prepared mice for intravital microscopy as described above. We acquired all videos with an Olympus BX61WI workstation using a LumPlanFl 60 Â water objective with numerical aperture 0.90 or a 10 Â water objective with numerical aperture 0.30, as previously described 25 , and analyzed them with SlideBook software (Intelligent Imaging Innovations). Detailed descriptions of in vivo identification of adherent leukocytes on inflamed venules, identification and quantification of platelet interactions, analysis of ESL-1 function, identification of leukocyte microdomains involved in RBC and platelet interactions, and analysis of vascular permeability are provided in the Supplementary Methods online.
Analysis of hemodynamic parameters in multichannel fluorescence intravital microscopy experiments. We calculated centerline RBC velocities (V RBC ), wall shear rates (g) and blood flow rates as described above. For experiments in which fluospheres were injected, we calculated V RBC values by dividing the distance traveled by the fastest free-flowing bead per frame by 0.022 s (capture rate: 45 frames per second, or 22 ms per frame. Hemodynamic parameters of mice analyzed for fluosphere capture are shown in Supplementary Table 2.
Statistical analyses. Unless otherwise indicated, data are presented as means ± s.e.m. and analyzed as follows. We analyzed parametric data (lung injury, microdomain analysis and hemodynamic analyses) with the analysis of variance t-test for two groups or with Tukey's multigroup comparison or Bonferroni's correction for more than two groups. We assessed statistical significance for nonparametric distributions (RBC-, platelet-or fluosphere-leukocyte interactions, vascular permeability and ROS production) with the Mann-Whitney test for two groups or the Kruskal-Wallis test with Dunn's multigroup comparison for more than two groups. We deemed a P value below 0.05 as significant. We used GraphPad Prism or Excel software for analyses.
Note: Supplementary information is available on the Nature Medicine website.
